Clinical Trials Browser

Phase 2 × Leukemia × revumenib × Clear all

NCT06229912 2026-02-19

A Phase II Study of the Menin Inhibitor Revumenib in Leukemia Associated With Upregulation of HOX Genes

Phase 2 Recruiting

Other hematologic neoplasm

Leukemia